MEDIROM Healthcare Technologies (MRM) Competitors $2.26 +0.13 (+6.10%) Closing price 04:00 PM EasternExtended Trading$2.37 +0.11 (+4.65%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MRM vs. CHGG, HCMA, STG, YSXT, NAMI, BEDU, KUKE, AACG, KIDZ, and FEDUShould you be buying MEDIROM Healthcare Technologies stock or one of its competitors? The main competitors of MEDIROM Healthcare Technologies include Chegg (CHGG), HCM Acquisition (HCMA), Sunlands Technology Group (STG), YSX Tech (YSXT), NAMI (NAMI), Bright Scholar Education (BEDU), Kuke Music (KUKE), ATA (AACG), Classover (KIDZ), and Four Seasons Education (Cayman) (FEDU). These companies are all part of the "personal services" industry. MEDIROM Healthcare Technologies vs. Its Competitors Chegg HCM Acquisition Sunlands Technology Group YSX Tech NAMI Bright Scholar Education Kuke Music ATA Classover Four Seasons Education (Cayman) MEDIROM Healthcare Technologies (NYSE:MRM) and Chegg (NYSE:CHGG) are both small-cap personal services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, valuation, dividends, profitability, earnings, analyst recommendations and risk. Does the media favor MRM or CHGG? In the previous week, Chegg had 1 more articles in the media than MEDIROM Healthcare Technologies. MarketBeat recorded 4 mentions for Chegg and 3 mentions for MEDIROM Healthcare Technologies. MEDIROM Healthcare Technologies' average media sentiment score of 0.84 beat Chegg's score of 0.39 indicating that MEDIROM Healthcare Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MEDIROM Healthcare Technologies 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Chegg 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders hold more shares of MRM or CHGG? 95.2% of Chegg shares are held by institutional investors. 40.2% of MEDIROM Healthcare Technologies shares are held by insiders. Comparatively, 3.7% of Chegg shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Do analysts recommend MRM or CHGG? Chegg has a consensus price target of $1.70, suggesting a potential upside of 35.46%. Given Chegg's higher probable upside, analysts plainly believe Chegg is more favorable than MEDIROM Healthcare Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MEDIROM Healthcare Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00Chegg 3 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.57 Is MRM or CHGG more profitable? MEDIROM Healthcare Technologies has a net margin of 0.00% compared to Chegg's net margin of -53.67%. MEDIROM Healthcare Technologies' return on equity of 0.00% beat Chegg's return on equity.Company Net Margins Return on Equity Return on Assets MEDIROM Healthcare TechnologiesN/A N/A N/A Chegg -53.67%-12.31%-3.27% Which has more volatility & risk, MRM or CHGG? MEDIROM Healthcare Technologies has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, Chegg has a beta of 1.77, meaning that its stock price is 77% more volatile than the S&P 500. Which has stronger valuation and earnings, MRM or CHGG? MEDIROM Healthcare Technologies has higher revenue and earnings than Chegg. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMEDIROM Healthcare Technologies$8.30B0.01$820KN/AN/AChegg$617.57M0.22-$837.07M-$2.61-0.48 SummaryMEDIROM Healthcare Technologies beats Chegg on 9 of the 14 factors compared between the two stocks. Get MEDIROM Healthcare Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for MRM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRM vs. The Competition Export to ExcelMetricMEDIROM Healthcare TechnologiesPersonal services IndustryMedical SectorNYSE ExchangeMarket Cap$64.16M$835.74M$5.62B$21.05BDividend YieldN/A2.11%4.61%3.56%P/E RatioN/A10.7530.2928.03Price / Sales0.0155.21463.4157.07Price / Cash1.4945.3738.2123.95Price / Book7.293.178.825.26Net Income$820K$39.59M$3.25B$994.11M7 Day Performance88.33%5.00%4.05%2.10%1 Month Performance64.36%1.59%4.32%0.99%1 Year Performance-13.74%199.48%36.25%15.24% MEDIROM Healthcare Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRMMEDIROM Healthcare Technologies1.6469 of 5 stars$2.26+6.1%N/A-26.6%$64.16M$8.30B0.00480News CoverageShort Interest ↓CHGGChegg4.2303 of 5 stars$1.40+10.7%$1.70+21.9%-38.9%$134.28M$617.57M-0.171,271HCMAHCM AcquisitionN/A$7.42+0.3%N/A-13.4%$104.93MN/A0.00N/ASTGSunlands Technology Group2.4562 of 5 stars$8.35+10.4%N/A+22.0%$102.20M$272.66M2.682,071News CoverageEarnings ReportShort Interest ↓Gap UpYSXTYSX TechN/A$3.12+4.3%N/AN/A$66.56MN/A0.0040Positive NewsGap UpNAMINAMIN/A$0.86-3.4%N/AN/A$60.85MN/A0.00N/AGap DownBEDUBright Scholar Education0.7537 of 5 stars$1.73-0.3%N/A-15.1%$51.43M$247.56M-0.372,193News CoverageShort Interest ↑KUKEKuke Music0.5157 of 5 stars$2.38+3.9%N/A-85.6%$46.54M$9.59M0.00170Gap DownAACGATA0.6526 of 5 stars$1.47+36.1%N/A+206.3%$34.46M$36.72M-10.50580High Trading VolumeKIDZClassoverN/A$1.33-8.0%N/AN/A$34.11MN/A0.00N/APositive NewsGap DownFEDUFour Seasons Education (Cayman)N/A$14.54+4.3%N/A+33.9%$31.50M$34.48M0.00290Gap Up Related Companies and Tools Related Companies Chegg Competitors HCM Acquisition Competitors Sunlands Technology Group Competitors YSX Tech Competitors NAMI Competitors Bright Scholar Education Competitors Kuke Music Competitors ATA Competitors Classover Competitors Four Seasons Education (Cayman) Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MRM) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MEDIROM Healthcare Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MEDIROM Healthcare Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access